Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Syzopride MV 1mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

3D Healthcare

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Syzopride MV 1mg/500mg/0.2mg Tablet

Diabetol-Trio 1mg/500mg/0.2mg tablets are classified as anti-diabetic medications. This triple-combination therapy is indicated for managing type 2 diabetes in adults, effectively regulating blood glucose levels. Diabetol-Trio should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation risks elevated glucose, potentially leading to complications such as renal impairment, visual disturbances, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan including diet modification, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect; learn to recognize symptoms like sweating, vertigo, cephalalgia, and tremors, and carry a readily available fast-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician prior to initiating treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring is essential, and your doctor might recommend blood tests to assess blood cell counts and liver function.

Uses of Syzopride MV 1mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Syzopride MV 1mg/500mg/0.2mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. Administer Syzopride MV 1mg/500mg/0.2mg tablets on an empty stomach.

Common Side effects of Syzopride MV 1mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Syzopride MV 1mg/500mg/0.2mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Syzopride MV 1mg/500mg/0.2mg tablets on an empty stomach.

How Syzopride MV 1mg/500mg/0.2mg Tablet works:

Each Syzopride MV tablet (1mg/500mg/0.2mg) combines three distinct antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Syzopride MV 1mg/500mg/0.2mg tablets is dangerous.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Syzopride MV 1mg/500mg/0.2mg tablets during pregnancy might pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against possible risks prior to prescription. Consult your doctor for advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Syzopride MV 1mg/500mg/0.2mg tablets while breastfeeding is likely unsafe. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Employing Syzopride MV 1mg/500mg/0.2mg tablets in individuals with kidney impairment poses a likely safety risk and is best avoided. Medical advice is recommended. Furthermore, this medication is unsuitable for patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Patients with liver impairment should use Syzopride MV 1mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiating treatment with a low dose is typical; however, the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Syzopride MV 1mg/500mg/0.2mg Tablet :

Should you forget a Syzopride MV 1mg/500mg/0.2mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Syzopride MV 1mg/500mg/0.2mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Syzopride MV 1mg/500mg/0.2mg Tablet

Syzopride MV 1mg/500mg/0.2mg tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not suitable for type 1 diabetes.
Syzopride MV 1mg/500mg/0.2mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste perception, flatulence, abdominal pain, headache, rash, and respiratory infections.
Patients with known allergies to Syzopride MV 1mg/500mg/0.2mg Tablet components or excipients, moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis (including diabetic ketoacidosis) should not use this medication.
Combining Syzopride MV 1mg/500mg/0.2mg tablets with alcohol is unsafe. This combination may worsen low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Syzopride MV 1mg/500mg/0.2mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Syzopride MV 1mg/500mg/0....
84
MRP 98
13% off